相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Glioblastomas with IDH1/2 mutations have a short clinical history and have a favorable clinical outcome
Makoto Ohno et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2016)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
Isocitrate Dehydrogenase (IDH) 1/2 Mutations as Prognostic Markers in Patients With Glioblastomas
Jun-Rui Chen et al.
MEDICINE (2016)
Moving the needle: Optimizing classification for glioma
Roel G. W. Verhaak
SCIENCE TRANSLATIONAL MEDICINE (2016)
A Time-Based and Intratumoral Proteomic Assessment of a Recurrent Glioblastoma Multiforme
Priscila F. de Aquino et al.
FRONTIERS IN ONCOLOGY (2016)
Charlson comorbidity index: an additional prognostic parameter for preoperative glioblastoma patient stratification
G. Ening et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2015)
Intratumoral heterogeneity in glioblastoma: don't forget the peritumoral brain zone
Jean-Michel Lemee et al.
NEURO-ONCOLOGY (2015)
Single cell-derived clonal analysis of human glioblastoma links functional and genomic heterogeneity
Mona Meyer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
PTEN deficiency reprogrammes human neural stem cells towards a glioblastoma stem cell-like phenotype
Shunlei Duan et al.
NATURE COMMUNICATIONS (2015)
PDGF receptors in tumor biology: prognostic and predictive potential
Janna Paulsson et al.
FUTURE ONCOLOGY (2014)
The Roles of PDGF in Development and During Neurogenesis in the Normal and Diseased Nervous System
Keiko Funa et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2014)
The combination of IDH1 mutations and MGMT methylation status predicts survival in glioblastoma better than either IDH1 or MGMT alone
Remco J. Molenaar et al.
NEURO-ONCOLOGY (2014)
Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma
Anoop P. Patel et al.
SCIENCE (2014)
Combined PTEN Mutation and Protein Expression Associate with Overall and Disease-Free Survival of Glioblastoma Patients
Jie Xu et al.
TRANSLATIONAL ONCOLOGY (2014)
Glioblastoma multiforme - an overview
Kaja Urbanska et al.
WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY (2014)
Deep sequencing of multiple regions of glial tumors reveals spatial heterogeneity for mutations in clinically relevant genes
Akash Kumar et al.
GENOME BIOLOGY (2014)
Glioblastoma and Other Malignant Gliomas A Clinical Review
Antonio Omuro et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Long-term survival of patients with glioblastoma multiforme (GBM)
Nicolas R. Smoll et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2013)
Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics
Andrea Sottoriva et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Multifarious functions of PDGFs and PDGFRs in tumor growth and metastasis
Yihai Cao
TRENDS IN MOLECULAR MEDICINE (2013)
PTEN loss represses glioblastoma tumor initiating cell differentiation via inactivation of Lgl1
Alexander Gont et al.
ONCOTARGET (2013)
Receptor Tyrosine Kinase Genes Amplified in Glioblastoma Exhibit a Mutual Exclusivity in Variable Proportions Reflective of Individual Tumor Heterogeneity
Suzanne E. Little et al.
CANCER RESEARCH (2012)
Platelet-derived growth factor receptors differentially inform intertumoral and intratumoral heterogeneity
Youngmi Kim et al.
GENES & DEVELOPMENT (2012)
Characterizing Mutational Heterogeneity in a Glioblastoma Patient with Double Recurrence
Gabrielle C. Nickel et al.
PLOS ONE (2012)
Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor response
Nicholas J. Szerlip et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
PDGF and PDGF receptors in glioma
Inga Nazarenko et al.
UPSALA JOURNAL OF MEDICAL SCIENCES (2012)
Gene expression profiling of gliomas: merging genomic and histopathological classification for personalised therapy
M. Vitucci et al.
BRITISH JOURNAL OF CANCER (2011)
Mosaic Amplification of Multiple Receptor Tyrosine Kinase Genes in Glioblastoma
Matija Snuderl et al.
CANCER CELL (2011)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis
HS Phillips et al.
CANCER CELL (2006)
Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets
DB Hoelzinger et al.
NEOPLASIA (2005)
Dose-dependent effects of platelet-derived growth factor-B on glial tumorigenesis
AH Shih et al.
CANCER RESEARCH (2004)
分享论文
